Skip to main content

Table 1 Population characteristics

From: Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease

 

CN (N = 573)

MCI (N = 124)

AD (N = 83)

P-value

Sex

 Female

318 (55.5%)

56.0 (45.2%)

48.0 (57.8%)

0.0859

 Male

255 (44.5%)

68.0 (54.8%)

35.0 (42.2%)

Age (years)

 Mean (SD)

72.9 (6.12)

75.6 (7.13)

75.0 (7.85)

< 0.001

 Median [Min, Max]

72.7 [60.0, 93.6]

76.3 [56.1, 95.4]

74.8 [57.8, 93.2]

APOEε4

 Absent

412 (71.9%)

66.0 (53.2%)

24.0 (28.9%)

< 0.001

 Present

161 (28.1%)

58.0 (46.8%)

59.0 (71.1%)

Education (years)

 0–6

1.00 (0.2%)

1.00 (0.8%)

2.00 (2.4%)

0.0148

 7–12

41.0 (7.2%)

17.0 (13.7%)

11.0 (13.3%)

 9–12

213 (37.2%)

50.0 (40.3%)

29.0 (34.9%)

 13–15

118 (20.6%)

22.0 (17.7%)

20.0 (24.1%)

 15+

200 (34.9%)

34.0 (27.4%)

21.0 (25.3%)

PHS

 Mean (SD)

0.0271 (0.763)

0.415 (0.967)

0.847 (0.941)

< 0.001

 Median [Min, Max]

−0.178 [−1.60, 2.59]

0.162 [−1.26, 3.12]

1.01 [−1.06, 2.91]

  1. P values determined by Fisher’s test (APOE ε4 and Gender), t-test (age), and Chi square analyses
  2. N number, CN cognitively normal, MCI mild cognitive impairment, AD Alzheimer’s disease, APOE ε4 apolipoprotein ε4 allele